Form 4: Rapport Therapeutics Director Buys Shares
Insider Transaction (Form 4)
Wendy B. Young, a Director of Rapport Therapeutics, Inc., purchased 3,789 shares of common stock on October 22, 2026 for $26.39 per share.
Summary
- Open-market purchase: acquired 3,789 Common Stock at $26.39 ($99,992) on October 22, 2026; holds 13,289 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $99,992, committing personal capital to the stock.
Insider Transactions
Wendy B. Young — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-22 | Open-market purchase | Common Stock | 3,789 | $26 | $100.0K | 13,289 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-22 | Open-market purchase (3,789 shares) |
Keywords
insider transaction, Form 4, RAPP, Rapport Therapeutics, Inc., bullish, Wendy B. Young
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.